Cargando…
Liposome Formulations for the Strategic Delivery of PARP1 Inhibitors: Development and Optimization
The development of a lipid nano-delivery system was attempted for three specific poly (ADP-ribose) polymerase 1 (PARP1) inhibitors: Veliparib, Rucaparib, and Niraparib. Simple lipid and dual lipid formulations with 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-(1′-glycerol) sodium salt (DPPG) and 1,2-dip...
Autores principales: | Conceição, Carlota J. F., Moe, Elin, Ribeiro, Paulo A., Raposo, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223686/ https://www.ncbi.nlm.nih.gov/pubmed/37242030 http://dx.doi.org/10.3390/nano13101613 |
Ejemplares similares
-
Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013) -
Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib
por: Moghimipour, Eskandar, et al.
Publicado: (2015) -
Editorial: Inhibiting PARP as a Strategic Target in Cancer
por: Zorn, Kristin K., et al.
Publicado: (2016) -
Optimization of liposomal encapsulation for ceftazidime for developing a potential eye drop formulation
por: Wijesooriya, Chamari, et al.
Publicado: (2013) -
Development and characterization of liposomal formulation of bortezomib
por: Deshantri, Anil K., et al.
Publicado: (2019)